Advanced search
Publication Cover
Expert Review of Cardiovascular Therapy Volume 10, 2012 - Issue 5
Submit an article Journal homepage
43
Views
0
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

How early is early enough to prevent stroke in atrial fibrillation?

Yutao Guo Haemostasis, Thrombosis and Vascular Biology Unit, University of Birmingham Centre for Cardiovascular Science, City Hospital, Birmingham, UK; Department of Geriatric Cardiology, Chinese PLA General Hospital, Beijing, China; Haemostasis, Thrombosis and Vascular Biology Unit, University of Birmingham Centre for Cardiovascular Science, City Hospital, Birmingham, UK; Department of Geriatric Cardiology, Chinese PLA General Hospital, Beijing, China
,
Gregory YH Lip Haemostasis, Thrombosis and Vascular Biology Unit, University of Birmingham Centre for Cardiovascular Science, City Hospital, Birmingham, UK; Haemostasis, Thrombosis and Vascular Biology Unit, University of Birmingham Centre for Cardiovascular Science, City Hospital, Birmingham, UK
&
Stavros Apostolakis Haemostasis, Thrombosis and Vascular Biology Unit, University of Birmingham Centre for Cardiovascular Science, City Hospital, Birmingham, UK; Haemostasis, Thrombosis and Vascular Biology Unit, University of Birmingham Centre for Cardiovascular Science, City Hospital, Birmingham, UK. [email protected]
Pages 585-588 | Published online: 10 Jan 2014

References

  • Mukherjee D, Patil CG. Epidemiology and the global burden of stroke. World Neurosurg. 76(Suppl. 6), S85–S90 (2011).
  • Banerjee A, Marín F, Lip GY. A new landscape for stroke prevention in atrial fibrillation: focus on new anticoagulants, antiarrhythmic drugs, and devices. Stroke 42(11), 3316–3322 (2011).
  • Ogilvie IM, Welner SA, Cowell W, Lip GY. Ischaemic stroke and bleeding rates in ‘real-world’ atrial fibrillation patients. Thromb. Haemost. 106(1), 34–44 (2011).
  • Liao J, Khalid Z, Scallan C, Morillo C, O’Donnell M. Noninvasive cardiac monitoring for detecting paroxysmal atrial fibrillation or flutter after acute ischemic stroke: a systematic review. Stroke 38(11), 2935–2940 (2007).
  • Disertori M, Lombardi F, Barlera S et al. Clinical characteristics of patients with asymptomatic recurrences of atrial fibrillation in the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico-Atrial Fibrillation (GISSI-AF) trial. Am. Heart J. 162(2), 382–389 (2011).
  • Glotzer TV, Hellkamp AS, Zimmerman J et al.; MOST Investigators. Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the Mode Selection Trial (MOST). Circulation 107(12), 1614–1619 (2003).
  • Botto GL, Padeletti L, Santini M et al. Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events. J. Cardiovasc. Electrophysiol. 20(3), 241–248 (2009).
  • Healey JS, Connolly SJ, Gold MR et al. Subclinical atrial fibrillation and the risk of stroke. N. Engl. J. Med. 366(2), 120–129 (2012).
  • Lazarus A. Remote, wireless, ambulatory monitoring of implantable pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy systems: analysis of a worldwide database. Pacing Clin. Electrophysiol. 30(1 Suppl.), S2–S12 (2007).
  • Glotzer TV, Daoud EG, Wyse DG et al. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circ. Arrhythm. Electrophysiol. 2(5), 474–480 (2009).
  • Daoud EG, Glotzer TV, Wyse DG et al.; TRENDS Investigators. Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: a subgroup analysis of TRENDS. Heart Rhythm 8(9), 1416–1423 (2011).
  • Shanmugam N, Boerdlein A, Proff J et al. Detection of atrial high-rate events by continuous home monitoring: clinical significance in the heart failure-cardiac resynchronization therapy population. Europace 14(2), 230–237 (2012).
  • Ip J, Waldo AL, Lip GY et al.; IMPACT Investigators. Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter – defibrillator and CRT-D devices: rationale, design, and clinical characteristics of the initially enrolled cohort The IMPACT study. Am. Heart J. 158(3), 364–370.e1 (2009).
  • Fonarow GC, Reeves MJ, Smith EE et al.; GWTG-Stroke Steering Committee and Investigators. Characteristics, performance measures, and in-hospital outcomes of the first one million stroke and transient ischemic attack admissions in get with the guidelines-stroke. Circ. Cardiovasc. Qual. Outcomes 3(3), 291–302 (2010).
  • Piccini JP, Daubert JP. Atrial fibrillation and stroke: it’s not necessarily all about the rhythm. Heart Rhythm 8(9), 1424–1425 (2011).
  • Adams RJ, Albers G, Alberts MJ et al.; American Heart Association; American Stroke Association. Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke 39(5), 1647–1652 (2008).
  • Welles CC, Whooley MA, Na B, Ganz P, Schiller NB, Turakhia MP. The CHADS2 score predicts ischemic stroke in the absence of atrial fibrillation among subjects with coronary heart disease: data from the Heart and Soul Study. Am. Heart J. 162(3), 555–561 (2011).
  • Boriani G, Botto GL, Padeletti L et al.; Italian AT-500 Registry Investigators. Improving stroke risk stratification using the CHADS2 and CHA2DS2-VASC risk scores in patients with paroxysmal atrial fibrillation by continuous arrhythmia burden monitoring. Stroke 42(6), 1768–1770 (2011).
  • RATE Steering Committee. RATE Investigators. Registry of Atrial Tachycardia and Atrial Fibrillation Episodes in the cardiac rhythm management device population: the RATE Registry design. Am. Heart. J. 157(6), 983–987.e1 (2009).
  • Kirchhof P, Lip GY, Van Gelder IC et al. Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options. executive summary of the report from the 3rd AFNET/EHRA consensus conference. Thromb. Haemost. 106(6), 1012–1019 (2011).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.